| LP422662-9 | Thinking about your current social habits, in the last 5 days: I have attended social gatherings outside my home of more than 10 people | COMPONENT | 1 |
| LP422663-7 | Thinking about your current social habits, in the last 5 days: I have attended social gatherings outside my home of less than 10 people | COMPONENT | 1 |
| LP422664-5 | Thinking about your current social habits, in the last 5 days: I have gone on shopping trips or outings that were just for fun | COMPONENT | 1 |
| LP422665-2 | Thinking about your current social habits, in the last 5 days: I have visited nursing homes or long-term care facilities (outside of work duties) | COMPONENT | 1 |
| LP422668-6 | How often in the past month are you doing the recommended pandemic hygiene | COMPONENT | 1 |
| LP422682-7 | I believe the country has become more dangerous for people in my racial/ethnic group because of fear of the coronavirus | COMPONENT | 1 |
| LP422683-5 | People of my race/ethnicity are more likely to lose their job because of the coronavirus | COMPONENT | 1 |
| LP422684-3 | I worry about people thinking I have the coronavirus simply because of my race/ethnicity | COMPONENT | 1 |
| LP422685-0 | Most social and mass media reports about the coronavirus create bias against people of my racial/ethnic group | COMPONENT | 1 |
| LP422686-8 | People of my race/ethnicity are more likely to get the coronavirus | COMPONENT | 1 |
| LP422687-6 | People of my race/ethnicity will not receive coronavirus healthcare as good as the care received by other groups | COMPONENT | 1 |
| LP422688-4 | Negative social media posts against people of my race/ethnicity have increased because of the coronavirus | COMPONENT | 1 |
| LP422690-0 | Carbon dioxide^at end expiration-Carbon dioxide^at end expiration+W sub-maximal exercise | COMPONENT | 1 |
| LP422692-6 | XXX^min | TIME | 3 |
| LP422698-3 | Core Outcome Measures Index for the Neck | COMPONENT | 1 |
| LP422699-1 | Which of the following problems related to your neck condition troubles you the most | COMPONENT | 1 |
| LP422700-7 | Pain severity and Body site panel | COMPONENT | 1 |
| LP422702-3 | How much did health condition interfere with normal work in past week | COMPONENT | 1 |
| LP422703-1 | Somatotropin post glucose stimulation panel | COMPONENT | 1 |
| LP422704-9 | If you had to spend the rest of your life with the symptoms you have right now how would you feel about it | COMPONENT | 1 |
| LP422705-6 | Quality of life in past week | COMPONENT | 1 |
| LP422706-4 | Number of days cut down on usual activities because of health condition in past 4 weeks | COMPONENT | 1 |
| LP422708-0 | Number of days did not go to work because of health condition in past 4 weeks | COMPONENT | 1 |
| LP422709-8 | Type of postoperative complication | COMPONENT | 1 |
| LP422710-6 | Postoperative complication distress level | COMPONENT | 1 |
| LP422711-4 | Subsequent operation for same health condition | COMPONENT | 1 |
| LP422713-0 | Treatment effectiveness | COMPONENT | 1 |
| LP422714-8 | Myasthenia gravis and Lambert-Eaton syndrome autoimmune Ab panel | COMPONENT | 1 |
| LP422726-2 | R-Outcomes | METHOD | 45 |
| LP422736-1 | SARS-CoV-2 (COVID-19) clade | COMPONENT | 1 |
| LP422739-5 | SARS-CoV-2 (COVID-19) lineage | COMPONENT | 3 |
| LP422740-3 | SARS-CoV-2 (COVID-19) sequencing and identification panel | COMPONENT | 1 |
| LP422743-7 | Clot initiation | COMPONENT | 8 |
| LP422746-0 | Interval between surgery and examination | COMPONENT | 1 |
| LP422752-8 | Megakaryoblasts | COMPONENT | |
| LP422753-6 | Promegakaryocytes | COMPONENT | |
| LP422754-4 | Entamoeba moshkovskii | COMPONENT | |
| LP422758-5 | Referral lab test | SYSTEM | 13 |
| LP422759-3 | Test result delivery method | COMPONENT | 1 |
| LP422762-7 | Hepatitis A virus cellular receptor 1 | COMPONENT | 2 |
| LP422763-5 | Fibroblast growth factor 19 | COMPONENT | 1 |
| LP422764-3 | Varicella zoster virus IgM Ab index | COMPONENT | 1 |
| LP422765-0 | Varicella zoster virus IgG Ab index | COMPONENT | 1 |
| LP422766-8 | Grimontia holisae and Vibrio fluvialis and Vibrio harveyi | COMPONENT | |
| LP422768-4 | Core Outcome Measures Index for the Back | COMPONENT | 1 |
| LP422774-2 | Phosphatidylserine-prothrombin complex IgG and IgM panel | COMPONENT | 1 |
| LP422812-0 | MDS v3.0 - RAI v1.16.1 - Bladder and bowel - NC | COMPONENT | 1 |
| LP422813-8 | MDS v3.0 - RAI v1.16.1 - Bladder and bowel - ND, SD | COMPONENT | 1 |
| LP422814-6 | MDS v3.0 - RAI v1.16.1 - Bladder and bowel - NP, NQ, SP | COMPONENT | 1 |
| LP422815-3 | MDS v3.0 - RAI v1.17.2 - Cognitive patterns - NC, NP, NQ, SP | COMPONENT | 1 |